Israel Innovation Authority

The Israel Innovation Authority is Israel’s statutory public agency responsible for advancing national technology innovation policy. It supports research and development, startup formation, applied industrial innovation, and innovation infrastructure through conditional grants, incentive programs, international collaboration tools, and policy advice to the government and Knesset committees.^[1]

Overview

The Israel Innovation Authority operates at the intersection of industrial policy, public finance, technology commercialization, and economic development. Its role is not that of a securities regulator or central bank; rather, it is a public-sector institution that allocates government-backed support to technological innovation where private financing may be insufficient, risky, or too short-term. In Israel’s financial ecosystem, the Authority is important because its grants and incentive programs can affect the financing path of startups, industrial companies, academic commercialization projects, and deep-technology ventures.

The Authority describes itself as an independent statutory authority charged with promoting innovation as a lever for inclusive and sustainable growth in Israel.^[1] It is responsible for innovation policy and operates for the benefit of the Israeli innovation ecosystem and the Israeli economy as a whole.^[2] Its mandate includes preserving and strengthening Israel’s technological leadership and entrepreneurial culture, increasing the economic value of innovation through output and exports, creating quality employment, and maintaining Israel’s position in global innovation.^[1]

The Authority’s activity is distinct from the work of the Bank of Israel, which conducts monetary policy and supervises banks, and from the Israel Securities Authority, which regulates securities markets. The Innovation Authority is closer to an industrial-development and innovation-finance institution: it uses public funding mechanisms to support R&D, reduce technology-development risk, and build innovation capacity in areas that may be strategically important to the Israeli economy.

Historical development

The Authority’s roots lie in the Office of the Chief Scientist, a central institution in Israel’s technology policy from the 1980s onward. According to the Authority, the structure of the Office of the Chief Scientist was redesigned in the mid-1980s and anchored in Israel’s research, development, and technological innovation legislation.^[1] The policy framework was designed to address national economic challenges, including the need to build knowledge-intensive industry during a period of economic stress and mass immigration.^[1]

The Office of the Chief Scientist developed tools that later became associated with Israel’s high-technology growth model. These included support for competitive R&D, the establishment of initiative funds to help create a venture-capital market, incubator programs intended to generate a pipeline of technology ventures, academia-industry collaboration programs, and mechanisms for opening international markets to Israeli companies.^[1]

In early 2016, the Office of the Chief Scientist became an independent authority known as the National Authority for Technological Innovation.^[1] The Authority replaced the Office of the Chief Scientist in the Ministry of Economy and the government association known as the Israel Industry Center for Research and Development, under Amendment No. 7 to the Law for the Encouragement of Research, Development and Technological Innovation in Industry.^[1]

The institutional restructuring was intended to provide more flexibility than the previous grant system. Under the former model, R&D grants were awarded by the chief scientist at the Ministry of Economy, while core terms such as royalties, rates, limits on transfer of know-how, and transfer of production abroad were largely determined by law or regulations.^[1] The Authority states that one goal of the legislative change was to transfer greater authority over grant conditions to the Authority’s council, allowing the creation of different benefit tracks and more adaptable terms.^[1]

Mandate and functions

The Authority’s principal mission is to drive sustainable economic growth through technological innovation.^[2] Its public functions include policy formulation, operation of funding and assistance tools, monitoring changes in innovation environments in Israel and abroad, and advising the government and Knesset committees on innovation policy.^[1]

The Authority provides conditional grants to support disruptive technological innovation and participates in building infrastructure for future technologies.^[2] Its support tools are intended to help Israel maintain technological and economic leadership, improve productivity, and strengthen global competitiveness.^[2] The Authority’s strategic pillars include direct investment in R&D where market failures exist, matched funding and conditional grants for innovative ventures, preparation of future ecosystems in fields such as quantum computing, artificial intelligence, bioconvergence, climate technology, and advanced manufacturing, and enabling competitiveness through human capital development, regulatory facilitation, and global market access.^[2]

In finance terms, the Authority’s grant-making can be understood as a form of public risk-sharing. Early-stage technology projects often involve scientific uncertainty, long development cycles, and limited collateral. Private investors may underfund such projects if expected returns are difficult to estimate or if benefits spill over to other firms and sectors. Conditional grants can therefore supplement venture capital, corporate R&D budgets, and academic technology-transfer channels. This does not make the Authority an investment adviser or a commercial investor; it is a public entity implementing government innovation policy.

Funding instruments and conditional grants

The Authority’s best-known financial instrument is the conditional grant. Conditional grants are typically associated with approved R&D plans and are subject to program rules. The Authority’s materials state that it provides a variety of practical tools and funding platforms designed to address changing needs in local and international innovation ecosystems.^[2]

Grant programs are governed by the Innovation Law, program provisions, rules, and procedures. In the Authority’s Startup Fund legal provisions, research committees are empowered to review applications, determine whether applicants meet threshold conditions, approve or reject applications, set conditions for approval, cancel or stop approved plans, and prescribe procedures for program execution.^[4] Program assistance is not automatic: the same document states that activating an incentive program and providing assistance are subject to annual budget approval, budget limitations, and the approved budget of the relevant incentive program.^[4]

The Authority’s programs may also involve repayment or royalty obligations depending on the specific track and the Innovation Law framework. The Startup Fund provisions state that royalty reporting and payment rules under the Innovation Law and the R&D Fund framework apply to grants and assistance under that program.^[4] The same provisions also refer to rules governing ownership of know-how developed under an approved plan, production in Israel, and the requirement not to transfer production or know-how outside Israel without prior approval by the relevant research committee.^[4]

These rules are financially significant. For companies receiving public R&D support, grant proceeds may reduce near-term financing needs or extend runway, but they may also create compliance obligations related to reporting, royalties, intellectual property, manufacturing location, and approval for transfers of know-how. For investors, such obligations can be relevant during due diligence, mergers and acquisitions, licensing transactions, and cross-border restructurings.

Organizational structure

The Authority is organized around innovation divisions rather than a single undifferentiated grant office. It states that its divisions are mission- and customer-oriented and provide adapted toolboxes for different users, such as early-stage entrepreneurs, mature companies developing products or production processes, academic research groups seeking commercialization, multinational corporations seeking collaboration with Israeli firms, Israeli companies pursuing foreign markets, and advanced manufacturing companies seeking innovation-based growth.^[1]

The Authority identifies a Growth and Advanced Manufacturing Division that helps young and mature companies grow through technological innovation, supports technological solutions for social and public purposes, and works to increase and diversify the supply of knowledge-rich human capital in the Israeli innovation system.^[1] It also identifies an International Collaborations Division that helps Israeli companies enter international markets by financing R&D collaborations with foreign companies.^[1]

The Authority’s leadership includes a chief executive. The Authority’s website identifies Dror Bin as chief executive officer and describes the Authority as an independent public entity that operates for the benefit of the Israeli innovation ecosystem and the Israeli economy as a whole.^[3] It states that his role is connected to nurturing Israeli innovation resources and creating and strengthening infrastructure and frameworks needed to support the knowledge industry.^[3]

Role in Israel’s high-technology economy

The Authority is one of the main public institutions connected to Israel’s high-technology sector. It describes innovation as a national asset and states that Israel hosts more than 500 R&D centers of multinational corporations.^[2] The Authority also states that its work is intended to strengthen the innovation ecosystem and promote innovation, entrepreneurship, and disruptive technologies as levers for inclusive and sustainable growth.^[2]

Its role is partly countercyclical and partly structural. In periods when private venture funding is abundant, public grants may still support areas with long development cycles, such as life sciences, advanced manufacturing, climate technology, semiconductors, quantum technologies, or other deep-technology fields. In periods when private funding is constrained, the Authority’s programs may become more visible as a source of non-dilutive or partially non-dilutive financing, although program availability remains subject to budget and eligibility rules.^[4]

The Authority also acts as an ecosystem coordinator. Its official description notes collaborations with other authorized authorities around the world to promote technological innovation in industry and the Israeli economy.^[1] It also identifies international collaborations as a specific division of activity, including financing R&D collaborations with foreign companies.^[1] This international role is important for a small open economy whose technology companies often rely on export markets, foreign strategic partners, multinational R&D centers, and cross-border capital.

Relationship with other public institutions

The Innovation Authority forms part of a wider Israeli public-finance and economic-policy system. The Ministry of Finance (Israel) is central to fiscal policy and government budgeting, while the Bank of Israel handles monetary policy and financial stability functions. The Israel Securities Authority regulates securities offerings, public companies, and capital-market activity. The Tel Aviv Stock Exchange provides a domestic listing and trading venue for securities.

The Innovation Authority’s role differs from each of these institutions. It does not set interest rates, supervise banks, or regulate public securities markets. Instead, it implements innovation policy through public support instruments. Its activities may nevertheless affect capital formation by helping companies reach technical milestones, making them more likely to attract private capital, enter strategic partnerships, license technology, or eventually list securities.

The Authority also interacts with the academic and industrial sectors. Its historical predecessor supported academia-industry collaboration through programs such as Magnet, and the current Authority continues to frame ecosystem development as one of its roles.^[1][2] In practice, this places the Authority between scientific research, industrial application, and private investment.

Legal and compliance considerations

Companies that receive Authority support are subject to the legal framework of the Innovation Law and program-specific procedures. The Startup Fund provisions illustrate several common compliance areas: application review by research committees, approved budgets, restrictions on duplicate public support for the same R&D components, rules concerning know-how and production, royalty reporting, audit rights, cancellation of assistance, and the need for budget approval before assistance is finalized.^[4]

The know-how and production restrictions are especially important in transactions. The program provisions state that grants and assistance are subject to rules concerning ownership of know-how stemming from approved R&D, production in Israel, and obligations not to transfer production outside Israel or transfer know-how or rights in that know-how without prior approval from the research committee.^[4] Such provisions can affect acquisition structures, intellectual-property transfers, offshore manufacturing plans, and licensing arrangements.

The Authority also has supervisory and enforcement powers under program rules. The Startup Fund provisions require recipients and investors to allow the Authority or parties acting on its behalf to audit their operations and to follow the Authority’s instructions as periodically determined.^[4] These obligations mean that Authority support is not simply a subsidy payment; it is a regulated public-support relationship.

Financial significance

For Israeli startups and technology companies, Authority support can influence capital structure and financing strategy. A conditional grant may reduce the amount of equity a company needs to raise at an early stage, thereby limiting immediate dilution for founders and existing shareholders. However, grants may carry obligations that investors and acquirers must evaluate, including royalties, reporting, and limits on transfers of know-how or production.

For venture capital and corporate investors, Authority-backed projects may signal that a company has passed a technical and administrative review process, though such approval is not a guarantee of commercial success. Conversely, public-support obligations can create transaction complexity. In due diligence, investors often review whether a company has received Innovation Authority grants, whether royalties are outstanding, whether all reports have been filed, and whether any planned transaction requires Authority approval.

For the Israeli economy, the Authority’s activities are part of a broader policy effort to sustain high-value employment, exports, and productivity growth. The Authority explicitly links innovation policy to output, exports, quality employment, and Israel’s global technology position.^[1] Its emphasis on fields such as AI, quantum computing, bioconvergence, climate technology, and advanced manufacturing reflects an attempt to support future technology platforms as well as current startup activity.^[2]

Criticism and policy debates

Public innovation agencies are often evaluated through several questions: whether they correct market failures effectively, whether they crowd in or crowd out private investment, whether grants reach firms and sectors with the highest social return, and whether compliance obligations are proportionate to the public funds provided. The Authority’s own historical account acknowledges that, under the former chief scientist model, some companies were reluctant to accept public support because of cumbersome grant management, lack of flexibility, and legal constraints on grant terms.^[1]

The 2016 institutional reform was designed to address some of those issues by creating a more flexible authority and allowing differentiated benefit tracks.^[1] Even with greater flexibility, the Authority’s programs remain public-budget instruments. They are therefore subject to annual budget approval and program limits, and they do not create an entitlement for any applicant to receive support.^[4]

See also

The Authority is closely connected to Israel’s innovation-finance environment and should be understood alongside the Israel Securities Authority, the Ministry of Finance (Israel), the Bank of Israel, and the Tel Aviv Stock Exchange. Together, these institutions shape different parts of the environment in which Israeli technology companies are financed, regulated, and commercialized.